CRISPR

Bibliographic References tagged with CRISPR

Not finding what you're looking for? Try using Advanced Search.
Not finding what you're looking for? Try using Advanced Search.
Housden B, Nicholson H, Perrimon N. Synthetic Lethality Screens Using RNAi in Combination with CRISPR-based Knockout in Cells.
Bio Protoc. 2017;7(3). PMID: 28523286
Housden B, Nicholson H, Perrimon N. Synthetic Lethality Screens Using RNAi in Combination with CRISPR-based Knockout in Cells.
Bio Protoc. 2017;7(3). PMID: 28523286
Jia Y, Xu RG, Ren X, Ewen-Campen B, Rajakumar R, Zirin J, Yang-Zhou D, Zhu R, Wang F, Mao D, Peng P, Qiao HH, Wang X, Liu LP, Xu B, Ji JY, Liu Q, Sun J, Perrimon N, Ni JQ. Next-generation CRISPR/Cas9 transcriptional activation in using flySAM.
Proc Natl Acad Sci U S A. 2018; PMID: 29666231
Jia Y, Xu RG, Ren X, Ewen-Campen B, Rajakumar R, Zirin J, Yang-Zhou D, Zhu R, Wang F, Mao D, Peng P, Qiao HH, Wang X, Liu LP, Xu B, Ji JY, Liu Q, Sun J, Perrimon N, Ni JQ. Next-generation CRISPR/Cas9 transcriptional activation in using flySAM.
Proc Natl Acad Sci U S A. 2018; PMID: 29666231
Ewen-Campen B, Mohr S, Hu Y, Perrimon N. Accessing the Phenotype Gap: Enabling Systematic Investigation of Paralog Functional Complexity with CRISPR.
Dev Cell. 2017;43(1):6–9. PMID: 29017030
Ewen-Campen B, Mohr S, Hu Y, Perrimon N. Accessing the Phenotype Gap: Enabling Systematic Investigation of Paralog Functional Complexity with CRISPR.
Dev Cell. 2017;43(1):6–9. PMID: 29017030
Housden B, Nicholson HE, Perrimon N. Synthetic Lethality Screens Using RNAi in Combination with CRISPR-based Knockout in Drosophila Cells.
Bio-Protocol. 2017;7(3).
Housden B, Nicholson HE, Perrimon N. Synthetic Lethality Screens Using RNAi in Combination with CRISPR-based Knockout in Drosophila Cells.
Bio-Protocol. 2017;7(3).
Housden B, Perrimon N. Comparing CRISPR and RNAi-based screening technologies.
Nat Biotechnol. 2016;34(6):621–3. PMID: 27281421
Housden B, Perrimon N. Comparing CRISPR and RNAi-based screening technologies.
Nat Biotechnol. 2016;34(6):621–3. PMID: 27281421
Mohr S, Hu Y, Ewen-Campen B, Housden B, Viswanatha R, Perrimon N. CRISPR guide RNA design for research applications.
FEBS J. 2016; PMID: 27276584
Mohr S, Hu Y, Ewen-Campen B, Housden B, Viswanatha R, Perrimon N. CRISPR guide RNA design for research applications.
FEBS J. 2016; PMID: 27276584
Lin S, Ewen-Campen B, Ni X, Housden B, Perrimon N. In Vivo Transcriptional Activation Using CRISPR/Cas9 in Drosophila.
Genetics. 2015;201(2):433–42. PMID: 26245833
Lin S, Ewen-Campen B, Ni X, Housden B, Perrimon N. In Vivo Transcriptional Activation Using CRISPR/Cas9 in Drosophila.
Genetics. 2015;201(2):433–42. PMID: 26245833
Housden B, Valvezan A, Kelley C, Sopko R, Hu Y, Roesel C, Lin S, Buckner M, Tao R, Yilmazel B, Mohr S, Manning B, Perrimon N. Identification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAi.
Sci Signal. 2015;8(393):rs9. PMID: 26350902
Housden B, Valvezan A, Kelley C, Sopko R, Hu Y, Roesel C, Lin S, Buckner M, Tao R, Yilmazel B, Mohr S, Manning B, Perrimon N. Identification of potential drug targets for tuberous sclerosis complex by synthetic screens combining CRISPR-based knockouts with RNAi.
Sci Signal. 2015;8(393):rs9. PMID: 26350902